Stockreport

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association [Yahoo! Finance]

Tiziana Life Sciences Ltd - Common Shares  (TLSA) 
PDF foralumab, for the treatment of Amyotrophic Lateral Sclerosis (ALS). The trial will evaluate the safety and early-stage parameters of disease improvement in ALS patients [Read more]